MSCI Inc. (NYSE:MSCI) Shares Bought by Cwm LLC

Cwm LLC grew its holdings in shares of MSCI Inc. (NYSE:MSCI – Get Rating) by 21.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,294 shares of the technology company’s stock after purchasing an additional 232 shares during the quarter. Cwm LLC’s holdings in MSCI were worth $546,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Bishop Rock Capital L.P. boosted its stake in MSCI by 18,898.0% during the 2nd quarter. Bishop Rock Capital L.P. now owns 3,918,722 shares of the technology company’s stock worth $9,508,000 after purchasing an additional 3,898,095 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of MSCI by 128.4% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 3,412,649 shares of the technology company’s stock worth $1,406,523,000 after acquiring an additional 1,918,640 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in shares of MSCI by 6.3% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,095,848 shares of the technology company’s stock worth $1,275,954,000 after acquiring an additional 183,590 shares during the period. Fiera Capital Corp raised its holdings in shares of MSCI by 1.0% during the 2nd quarter. Fiera Capital Corp now owns 2,047,599 shares of the technology company’s stock worth $843,918,000 after acquiring an additional 19,589 shares during the period. Finally, Capital International Investors raised its holdings in shares of MSCI by 10.6% during the 1st quarter. Capital International Investors now owns 1,338,596 shares of the technology company’s stock worth $673,346,000 after acquiring an additional 127,820 shares during the period. Institutional investors and hedge funds own 88.18% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on MSCI shares. Oppenheimer reduced their price target on MSCI to $504.00 in a report on Wednesday, October 5th. Atlantic Securities lifted their price target on MSCI from $444.00 to $498.00 in a report on Monday, November 7th. Barclays lifted their price target on MSCI from $470.00 to $600.00 and gave the stock an “overweight” rating in a report on Friday, December 2nd. Morgan Stanley lifted their price target on MSCI from $500.00 to $518.00 and gave the stock an “equal weight” rating in a report on Wednesday, January 4th. Finally, Raymond James boosted their price objective on shares of MSCI from $499.00 to $514.00 and gave the company an “outperform” rating in a report on Wednesday, October 26th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $529.20.

Insider Buying and Selling at MSCI

In other MSCI news, insider Scott A. Crum sold 7,500 shares of the firm’s stock in a transaction that occurred on Thursday, October 27th. The shares were sold at an average price of $460.00, for a total value of $3,450,000.00. Following the completion of the transaction, the insider now owns 19,908 shares of the company’s stock, valued at approximately $9,157,680. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CFO Andrew C. Wiechmann sold 1,100 shares of MSCI stock in a transaction on Thursday, November 3rd. The shares were sold at an average price of $453.38, for a total transaction of $498,718.00. Following the completion of the sale, the chief financial officer now directly owns 15,908 shares of the company’s stock, valued at approximately $7,212,369.04. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Scott A. Crum sold 7,500 shares of MSCI stock in a transaction on Thursday, October 27th. The stock was sold at an average price of $460.00, for a total transaction of $3,450,000.00. Following the sale, the insider now directly owns 19,908 shares of the company’s stock, valued at $9,157,680. The disclosure for this sale can be found here. 3.02% of the stock is currently owned by corporate insiders.

MSCI Stock Performance

Shares of MSCI opened at $504.12 on Thursday. The company’s 50-day simple moving average is $485.16 and its 200-day simple moving average is $461.01. MSCI Inc. has a 1 year low of $376.41 and a 1 year high of $568.00. The stock has a market capitalization of $40.31 billion, a PE ratio of 48.61 and a beta of 1.11.

MSCI (NYSE:MSCI – Get Rating) last announced its earnings results on Tuesday, October 25th. The technology company reported $2.85 earnings per share for the quarter, topping the consensus estimate of $2.76 by $0.09. MSCI had a net margin of 38.23% and a negative return on equity of 115.88%. The firm had revenue of $560.64 million for the quarter, compared to the consensus estimate of $564.96 million. On average, sell-side analysts predict that MSCI Inc. will post 11.32 earnings per share for the current year.

MSCI Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 30th. Shareholders of record on Thursday, November 10th were given a $1.25 dividend. The ex-dividend date of this dividend was Wednesday, November 9th. This represents a $5.00 annualized dividend and a yield of 0.99%. MSCI’s dividend payout ratio is presently 48.22%.

MSCI Company Profile

(Get Rating)

MSCI Inc, together with its subsidiaries, provides investment decision support tools for the clients to manage their investment processes worldwide. It operates through four segments: Index, Analytics, ESG and Climate, and All Other – Private Assets. The Index segment provides indexes for use in various areas of the investment process, including indexed product creation, such as ETFs, mutual funds, annuities, futures, options, structured products, over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct.